This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Testicular dysfunction
E4_TESTIDYS
testicular disease: A non-neoplastic or neoplastic disorder affecting the testis. Representative examples include torsion, infarction, germ cell tumor, sex cord-stromal tumor, lymphoma, and leukemia.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1091 |
4. Check minimum number of eventsNone |
1091 |
5. Include endpoints |
1333 |
6. Filter based on genotype QC (FinnGen only) |
1333 |
Control definitions (FinnGen only)
- Control exclude
- E4_ENDOGLAND
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E20-E35
- Name in latin
- Dysfunctio testicularis
Similar endpoints
↥List of similar endpoints to
Testicular dysfunction
based on the number of shared cases.
Similar with more cases:
- Disorders of other endocrine glands
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1333 | - | 1333 |
| Unadjusted period prevalence (%) | 0.59 | - | 0.59 |
| Median age at first event (years) | 51.79 | - | 51.79 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1175
- Matched controls
- 11750
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
121
Kela drug reimbursment
Severe hypofunction of sexual glands
389.7
323.0
391
15
E29.1
ICD-10 Finland
Testicular hypofunction
548.9
323.0
882
64
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
118.6
323.0
986
493
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
85.2
163.2
181
25
E29.9
ICD-10 Finland
Testicular dysfunction, unspecified
118.7
91.5
98
9
Y28
ICPC
Limited function/disability (Y)
42.3
86.6
108
28
A50
ICPC
General and Unspecified, Medication/prescr/renewal
14.1
83.9
148
119
A55
ICPC
General and Unspecified, Local injection/infiltration
28.2
64.9
89
34
101
Kela drug reimbursment
Anterior pituitary hypofunction
+∞
63.1
60
*
G47.3
ICD-10 Finland
Sleep apnoea
2.9
55.2
454
2101
E29.8
ICD-10 Finland
Other testicular dysfunction
125.0
45.1
48
*
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
9.4
41.9
89
102
G03GA01
ATC
chorionic gonadotrophin; parenteral
35.5
39.7
51
15
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
30.2
38.9
52
18
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.2
35.4
495
2877
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
5.5
34.5
107
211
N48.4
ICD-10 Finland
Impotence of organic origin
5.8
32.1
95
177
KFC00
NOMESCO Finland
Unilateral orchiectomy
14.5
31.8
54
39
G04CA01
ATC
alfuzosin; oral
2.7
30.9
247
1063
R5140
NOMESCO Finland
Monitoring the use of the aid
2.9
30.8
216
856
N03AX16
ATC
pregabalin; oral
2.5
30.5
291
1379
N02AX02
ATC
tramadol; systemic, rectal
2.1
30.5
529
3314
M01AH05
ATC
etoricoxib; oral
2.1
30.4
726
5174
H03AA01
ATC
levothyroxine sodium; systemic
3.2
30.3
176
615
N06AX11
ATC
mirtazapine; oral
2.2
29.9
385
2112
E29
ICD-10 Finland
Testicular dysfunction
102.6
27.8
30
*
A02BC05
ATC
esomeprazole; systemic
2.1
27.7
449
2702
N05BA04
ATC
oxazepam; oral
2.4
27.0
274
1329
T99
ICPC
Endocr/metab/nutrit disease other
10.2
26.2
52
53
N06AB10
ATC
escitalopram; oral
2.4
25.6
257
1236
N03AX12
ATC
gabapentin; oral
2.7
25.2
195
814
H02AB09
ATC
hydrocortisone; systemic
15.1
24.8
41
28
N06AX12
ATC
bupropion; oral
3.5
24.7
123
381
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.9
24.0
565
3859
N06AX16
ATC
venlafaxine; oral
2.6
23.6
186
783
J01MA02
ATC
ciprofloxacin; systemic
1.9
23.3
437
2737
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.6
23.1
188
804
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
22.9
324
1814
A02BC02
ATC
pantoprazole; systemic
1.8
22.7
681
5017
J01DB01
ATC
cefalexin; oral
2.0
22.3
950
7910
R53
ICD-10 Finland
Malaise and fatigue
2.4
22.0
203
929
N06AX26
ATC
vortioxetine; oral
3.7
21.8
99
285
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
21.6
476
3140
N06AX21
ATC
duloxetine; oral
2.9
21.5
137
506
N05CF02
ATC
zolpidem; oral
2.3
21.4
218
1048
-50
ICPC
Medication/prescr/renewal
5.0
21.4
70
147
M03BX02
ATC
tizanidine; oral
1.8
21.2
740
5676
N02AJ06
ATC
codeine and paracetamol; systemic
1.9
21.2
473
3129
J01FA10
ATC
azithromycin; systemic
1.8
21.1
637
4653
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.2
21.1
115
382
J01CA04
ATC
amoxicillin; systemic
1.9
20.8
901
7412
A06AC01
ATC
ispaghula (psylla seeds); oral
2.3
20.8
214
1033
T28
ICPC
Limited function/disability (T)
16.1
20.6
33
21
Q98.0
ICD-10 Finland
Klinefelter syndrome karyotype 47,XXY
112.0
20.6
22
*
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
9.8
20.4
41
43
R03AC02
ATC
salbutamol; inhalant
1.8
19.7
544
3829
N62
ICD-10 Finland
Hypertrophy of breast
7.9
19.7
45
59
N02BE01
ATC
paracetamol; systemic, rectal
1.9
19.3
924
7740
R01AD09
ATC
mometasone; nasal
1.8
18.9
479
3266
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
+∞
18.8
18
*
N05CF01
ATC
zopiclone; oral
1.9
18.8
323
1929
XKD00
NOMESCO Finland
Uroflowmetry
2.2
18.7
223
1147
N06AB04
ATC
citalopram; systemic
2.1
18.7
231
1210
N05AH04
ATC
quetiapine; oral
2.1
18.5
228
1191
D75.1
ICD-10 Finland
Secondary polycythaemia
12.1
18.4
33
28
M03BC51
ATC
orphenadrine, combinations; systemic
1.9
18.3
316
1888
M54.5
ICD-10 Finland
Low back pain
1.9
18.2
367
2312
M01AB05
ATC
diclofenac; systemic, rectal
1.8
18.2
780
6220
E23.00
ICD-10 Finland
Panhypopituitarism
+∞
17.7
17
*
J01AA02
ATC
doxycycline; systemic
1.8
17.5
831
6792
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
17.5
324
1977
T55
ICPC
Metabolic, Local injection/infiltration
29.3
17.5
23
8
UKC02
NOMESCO Finland
Cystoscopy
2.3
17.2
179
864
N46
ICD-10 Finland
Male infertility
4.4
16.8
62
148
M03BC01
ATC
orphenadrine (citrate); systemic
1.9
16.7
285
1684
R01AD12
ATC
fluticasone furoate; nasal
1.9
16.7
318
1956
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
16.7
556
4068
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.9
16.7
310
1891
R06.0
ICD-10 Finland
Dyspnoea
2.0
16.7
230
1255
WX723
NOMESCO Finland
CPAP therapy
3.4
16.6
83
258
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
16.6
195
994
R01AD08
ATC
fluticasone; nasal
1.9
16.5
310
1895
T50
ICPC
Metabolic, Medication/prescr/renewal
40.7
16.4
20
5
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.7
16.3
114
443
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
21.3
16.0
23
11
H02AB06
ATC
prednisolone; systemic
1.7
15.8
457
3195
N40
ICD-10 Finland
Hyperplasia of prostate
1.9
15.8
271
1601
M01AC06
ATC
meloxicam; systemic, rectal
1.8
15.7
363
2372
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.4
15.6
78
243
R06.5
ICD-10 Finland
Mouth breathing
2.3
15.1
151
712
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.5
15.0
53
122
M48.0
ICD-10 Finland
Spinal stenosis
2.6
14.9
114
469
L02BA01
ATC
tamoxifen; oral
25.4
14.7
20
8
M01AE02
ATC
naproxen; oral, rectal
1.6
14.6
601
4596
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
14.4
14.6
24
17
M54.4
ICD-10 Finland
Lumbago with sciatica
2.1
14.5
184
966
Q98.4
ICD-10 Finland
Klinefelter syndrome, unspecified
151.8
14.5
15
*
A02BC03
ATC
lansoprazole; oral
1.8
14.4
282
1736
E66.00
ICD-10 Finland
Metabolic syndrome
3.0
14.4
87
310
R06AX27
ATC
desloratadine; oral
1.8
14.3
271
1650
Y50
ICPC
Male Genital, Medication/prescr/renewal
27.5
14.3
19
7
E66.01
ICD-10 Finland
Obesity due to excess calories
2.8
14.2
92
343
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.1
14.2
178
930
J02AC01
ATC
fluconazole; systemic
1.9
14.2
220
1246
N06AB06
ATC
sertraline; oral
2.4
14.0
127
569
N05BA12
ATC
alprazolam; oral
2.4
14.0
120
525
C09CA06
ATC
candesartan; oral
1.9
14.0
224
1287
A02BC01
ATC
omeprazole; systemic
1.8
13.9
253
1521
WX780
NOMESCO Finland
Remote monitoring CPAP
2.9
13.9
84
299
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
13.8
553
4179
L02BG04
ATC
letrozole; oral
13.8
13.7
23
17
R52.2
ICD-10 Finland
Other chronic pain
4.6
13.6
47
106
P01AB01
ATC
metronidazole; oral, rectal
1.7
13.5
315
2045
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
13.5
278
1736
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
13.4
228
1333
C07AA05
ATC
propranolol; systemic
2.0
13.4
187
1018
R06AE07
ATC
cetirizine; oral
1.6
13.3
416
2933
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.7
13.3
58
163
SPAT1254
SPAT
Administration of medicine
2.2
13.2
137
656
M79.6
ICD-10 Finland
Pain in limb
1.7
13.2
322
2116
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.2
13.1
147
729
J05AB01
ATC
aciclovir; systemic
2.0
13.0
177
955
L02BG03
ATC
anastrozole; oral
22.8
12.9
18
8
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.2
12.9
68
222
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
3.6
12.8
57
163
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
12.8
151
765
F51.0
ICD-10 Finland
Nonorganic insomnia
2.2
12.8
138
672
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.8
12.7
248
1520
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.4
12.7
109
478
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.9
12.6
221
1307
J01FA06
ATC
roxithromycin; oral
1.6
12.5
393
2765
E29.0
ICD-10 Finland
Testicular hyperfunction
+∞
12.5
12
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
12.4
226
1352
E0000UV
ATC
NA
1.6
12.3
361
2491
R50.9
ICD-10 Finland
Fever, unspecified
2.1
12.3
156
816
R51.80
ICD-10 Finland
Headache
2.1
12.3
141
706
N04BC05
ATC
pramipexole; oral
2.9
12.1
72
255
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.3
12.1
111
503
N05CD07
ATC
temazepam; oral
2.3
12.1
117
542
AA1AD
NOMESCO Finland
CT of head and brain
1.8
12.0
228
1379
L03
ICPC
Low back symptom/complaint
1.8
12.0
215
1279
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.1
11.8
138
695
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
65.6
11.6
13
*
WVA30
SPAT
NA
3.8
11.6
48
130
N06AB03
ATC
fluoxetine; oral
2.2
11.5
126
620
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
11.5
239
1488
J01FA09
ATC
clarithromycin; systemic
1.7
11.5
310
2085
E30.09
ICD-10 Finland
Delayed puberty NOS
+∞
11.5
11
*
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.6
11.4
82
324
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.9
11.4
70
251
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
11.4
258
1650
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.5
11.3
91
383
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
11.3
329
2258
P06
ICPC
Sleep disturbance
2.2
11.3
112
527
J01MA12
ATC
levofloxacin; systemic
1.8
11.2
193
1129
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
20.2
11.1
16
8
G04CA02
ATC
tamsulosin; oral
1.7
11.0
285
1893
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.4
11.0
98
437
E22.1
ICD-10 Finland
Hyperprolactinaemia
43.7
10.9
13
*
H02AB04
ATC
methylprednisolone; systemic
2.0
10.9
138
720
XW000
NOMESCO Finland
Bone marrow biopsy
3.4
10.9
52
158
S50
ICPC
Skin, Medication/prescr/renewal
12.0
10.9
19
16
S55
ICPC
Skin, Local injection/infiltration
15.7
10.8
17
11
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
10.8
452
3388
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.7
10.8
257
1665
Y05
ICPC
Scrotum/testis sympt/compl other
5.0
10.6
33
68
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.9
10.5
63
225
J01FF01
ATC
clindamycin; systemic
1.6
10.5
294
1991
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.2
10.5
54
174
N06BA04
ATC
methylphenidate; oral
4.2
10.5
39
96
T29
ICPC
Endocr/metab/nutr sympt/compl other
5.3
10.5
31
60
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
2.1
10.5
118
586
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.7
10.5
245
1578
H01AC01
ATC
somatropin; parenteral
+∞
10.4
10
*
R01BA52
ATC
pseudoephedrine, combinations; oral
1.6
10.4
289
1953
J05AB11
ATC
valaciclovir; oral
2.1
10.4
118
591
J01EA01
ATC
trimethoprim; systemic
2.3
10.3
93
415
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
10.3
119
596
M04AA01
ATC
allopurinol; systemic
2.0
10.3
141
759
A02BC04
ATC
rabeprazole; oral
2.4
10.1
87
382
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.8
10.0
175
1030
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
40.4
10.0
12
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
10.0
152
853
C08CA01
ATC
amlodipine; oral
1.6
9.9
319
2232
SPAT1262
SPAT
Handing over of treatment supplies
1.7
9.9
205
1270
UDC00
NOMESCO Finland
Ear microscopy
2.5
9.9
79
331
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
16.9
9.9
15
9
Y99
ICPC
Genital disease male other
12.3
9.9
17
14
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
9.7
222
1418
M25.5
ICD-10 Finland
Pain in joint
1.6
9.7
257
1710
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
9.7
169
990
R03DC03
ATC
montelukast; oral
1.9
9.7
137
747
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
3.4
9.7
45
135
C10AA07
ATC
rosuvastatin; oral
1.7
9.6
243
1593
E66.8
ICD-10 Finland
Other obesity
2.8
9.6
61
226
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
9.6
168
984
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
9.5
226
1457
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.3
9.5
85
379
S01GX01
ATC
cromoglicic acid; ophthalmic
1.8
9.5
165
966
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.5
9.5
71
291
UJF32
NOMESCO Finland
Coloscopy
1.7
9.4
222
1426
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.5
9.4
74
310
Y55
ICPC
Male Genital, Local injection/infiltration
100.8
9.4
10
*
E23.09
ICD-10 Finland
Pituitary insufficiency NOS
+∞
9.4
9
*
2572A
ICD-9 Finland
Testicular dysfunction, Other testicular hypofunction
+∞
9.4
9
*
R03BA08
ATC
ciclesonide; inhalant
2.4
9.3
77
332
OAB72
NOMESCO Finland
Weight control and weight loss guidance
10.8
9.3
17
16
R06AX22
ATC
ebastine; oral
1.8
9.3
155
897
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
13.8
9.2
15
11
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.8
9.2
166
984
N06AA12
ATC
doxepin; systemic
2.7
9.2
59
222
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.3
9.1
86
396
A98
ICPC
Health maint/preventive medicine
2.1
9.1
1112
10491
J01DA01
ATC
[U] cefalexin; systemic
1.5
9.1
621
5107
N06AB05
ATC
paroxetine; oral
2.4
9.1
77
336
R60.0
ICD-10 Finland
Localized oedema
2.2
9.0
88
412
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
4.3
9.0
32
76
WX320
NOMESCO Finland
Spinalanesthesy
1.7
9.0
189
1172
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
9.0
151
875
N41.1
ICD-10 Finland
Chronic prostatitis
2.9
9.0
53
189
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.1
8.9
47
155
R03AK07
ATC
formoterol and budesonide; inhalant
1.7
8.9
190
1187
WX110
NOMESCO Finland
Local anesthesy
1.5
8.9
745
6370
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
8.8
102
515
A06AD11
ATC
lactulose; oral
2.0
8.8
106
544
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
8.8
399
3011
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
8.7
277
1923
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.7
8.7
57
217
M02AA07
ATC
piroxicam; topical
1.5
8.7
315
2258
H05BX01
ATC
cinacalcet; oral
50.4
8.7
10
*
N06AX22
ATC
agomelatine; oral
4.0
8.7
33
84
C03CA01
ATC
furosemide; systemic
1.7
8.7
180
1116
N02AA05
ATC
oxycodone; systemic
1.9
8.7
121
656
C07AB07
ATC
bisoprolol; oral
1.5
8.7
405
3075
L28
ICPC
Limited function/disability (L)
2.0
8.6
103
526
A03FA01
ATC
metoclopramide; systemic, rectal
1.9
8.6
139
794
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.3
8.6
79
357
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.5
8.6
65
267
M54.2
ICD-10 Finland
Cervicalgia
2.4
8.6
72
314
M79.1
ICD-10 Finland
Myalgia
2.0
8.6
105
543
L08
ICPC
Shoulder symptom/complaint
1.8
8.6
169
1029
G04BD12
ATC
mirabegron; oral
2.4
8.5
72
315
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.6
8.5
259
1781
N03AE01
ATC
clonazepam; systemic
2.4
8.5
68
289
N05BA01
ATC
diazepam; systemic, rectal
1.8
8.5
140
807
M01AH01
ATC
celecoxib; oral (coxibs)
1.8
8.5
150
885
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
8.4
190
1205
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
90.7
8.4
9
*
E23.05
ICD-10 Finland
Lack of TSH
90.7
8.4
9
*
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
90.7
8.4
9
*
Z01.2
ICD-10 Finland
Dental examination
1.5
8.4
392
2968
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
+∞
8.3
8
*
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
+∞
8.3
8
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
8.2
289
2052
M01AX05
ATC
glucosamine; oral
1.9
8.2
116
633
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.2
8.2
41
131
M01AB55
ATC
diclofenac, combinations; oral
2.7
8.2
54
207
127
Kela drug reimbursment
Transplant complication
3.9
8.2
32
84
J01AA04
ATC
lymecycline; systemic
1.9
8.2
130
738
SPAT1263
SPAT
Sampling
1.5
8.2
380
2872
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
8.1
413
3177
ZXA05
NOMESCO Finland
Left side
1.6
8.1
225
1508
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
33.6
8.1
10
*
Y08
ICPC
Sexual function sympt/compl male
6.9
8.1
19
28
75210
ICD-8 Finland
Congenital anomalies of genital organs, Undescended testicle
3.8
8.1
32
85
H02.3
ICD-10 Finland
Blepharochalasis
3.2
8.1
41
133
N03AX09
ATC
lamotrigine; oral
2.5
8.0
61
251
R52.9
ICD-10 Finland
Pain, unspecified
2.3
8.0
75
345
SPAT1310
SPAT
Counselling related to known health issue
1.5
7.9
283
2016
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
7.9
757
6563
A02BA02
ATC
ranitidine; systemic
1.7
7.8
158
970
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
7.8
337
2503
M19.0
ICD-10 Finland
Primary arthrosis of other joints
2.1
7.8
88
438
X58
ICD-10 Finland
Exposure to other specified factors
1.6
7.7
188
1218
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
2.3
7.6
68
305
H02AB07
ATC
prednisone; oral
1.9
7.6
113
626
KFA00
NOMESCO Finland
Exploration of testis
8.1
7.6
16
20
M81.9
ICD-10 Finland
Osteoporosis, unspecified
5.2
7.6
22
43
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.1
7.6
84
415
R35
ICD-10 Finland
Polyuria
2.3
7.5
68
309
J01MA01
ATC
ofloxacin; systemic
2.1
7.5
80
391
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
7.5
507
4104
M05BA04
ATC
alendronic acid; oral
3.2
7.5
37
118
WX722
NOMESCO Finland
PEEP
2.4
7.5
61
262
R06AX13
ATC
loratadine; oral
1.8
7.5
133
786
G44.2
ICD-10 Finland
Tension-type headache
2.0
7.4
92
477
L01
ICPC
Neck symptom/complaint
1.9
7.4
100
537
R03AC03
ATC
terbutaline; inhalant
1.8
7.3
123
711
R03BA05
ATC
fluticasone; inhalant
1.7
7.3
156
973
G03GA02
ATC
human menopausal gonadotrophin; parenteral
+∞
7.3
7
*
E23.03
ICD-10 Finland
Lack of ACTH
+∞
7.3
7
*
SPAT1325
SPAT
Vaccination
1.5
7.3
244
1708
R05FA02
ATC
opium derivatives and expectorants; systemic
1.5
7.2
342
2582
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
7.2
590
4926
KED22
NOMESCO Finland
Transurethral resection of prostate
2.4
7.1
59
255
N06AA09
ATC
amitriptyline; systemic
2.1
7.1
79
392
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.9
7.1
109
612
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.1
7.1
83
419
A99
ICPC
Disease/condition unspecnature/site
2.2
7.1
67
309
F34.1
ICD-10 Finland
Dysthymia
2.9
7.1
41
145
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.1
7.1
36
118
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
7.0
660
5641
R02
ICPC
Shortness of breath/dyspnoea
1.9
6.9
94
503
SPAT1301
SPAT
No procedures
1.5
6.9
259
1860
L17
ICPC
Foot/toe symptom/complaint
1.6
6.9
193
1292
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
6.9
116
671
L03AA02
ATC
filgrastim; parenteral
3.4
6.9
31
93
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
8.3
6.8
14
17
N06AG02
ATC
moclobemide; oral
2.5
6.8
49
199
C09DA03
ATC
valsartan and diuretics; oral
2.6
6.8
48
192
R01AD01
ATC
beclometasone; nasal
1.7
6.8
145
906
N18.8
ICD-10 Finland
Other chronic renal failure
3.0
6.8
36
122
G03GA05
ATC
follitropin alfa; parenteral
40.3
6.8
8
*
B01AB05
ATC
enoxaparin; parenteral
1.5
6.8
234
1648
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.4
6.7
30
89
SPAT1312
SPAT
General health counselling
1.5
6.7
272
1981
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.5
6.7
48
194
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.2
6.7
69
331
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.2
6.7
65
306
C02AC05
ATC
moxonidine; oral
2.6
6.7
45
176
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
2.6
6.7
47
187
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.0
6.7
82
423
R74
ICPC
Upper respiratory infection acute
1.5
6.6
237
1683
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
3.0
6.6
36
124
A04
ICPC
Weakness/tiredness general
1.9
6.6
90
487
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
12.3
6.6
11
9
M54.1
ICD-10 Finland
Radiculopathy
2.6
6.6
44
172
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.8
6.6
101
570
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.7
6.5
123
737
C09CA03
ATC
valsartan; oral
2.0
6.5
85
450
OAA65
SPAT
NA
1.8
6.5
118
700
SPAT1094
SPAT
Continuous Positive Airway Pressure
4.2
6.5
23
56
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.0
6.5
77
394
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
6.5
89
481
T90
ICPC
Diabetes non-insulin dependent
1.5
6.5
227
1604
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
6.5
151
964
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
6.4
63
298
AA4DG
NOMESCO Finland
Very extensive MRI examination of sella turcica with high intensity magnet
70.2
6.4
7
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
14.4
6.4
10
7
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
14.4
6.4
10
7
ZX120
NOMESCO Finland
Intravenous
2.0
6.4
82
432
D07AC13
ATC
mometasone; topical
1.5
6.4
264
1934
L57.0
ICD-10 Finland
Actinic keratosis
2.3
6.3
57
259
R39.1
ICD-10 Finland
Other difficulties with micturition
2.7
6.3
41
157
N04BC06
ATC
cabergoline; oral (dopamine agonists)
18.1
6.3
9
5
Q53.9
ICD-10 Finland
Undescended testicle, unspecified
+∞
6.3
6
*
Y10
ICPC
Infertility/subfertility male
26.8
6.2
8
*
N01
ICPC
Headache
2.1
6.2
66
323
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
1.9
6.2
94
526
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
6.2
103
596
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.8
6.2
105
613
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.5
6.2
45
185
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.0
6.2
72
366
7525A
ICD-9 Finland
Congenital anomalies of genital organs, Undescended testicle[RETENTIO TESTIS (CRYPTORCHISMUS)]
6.3
6.2
15
24
C08CA13
ATC
lercanidipine; oral
1.8
6.2
103
598
-55
ICPC
Local injection/infiltration
7.7
6.1
13
17
R01AD11
ATC
triamcinolone; nasal
1.9
6.1
80
427
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.9
6.1
88
487
R42
ICD-10 Finland
Dizziness and giddiness
1.6
6.1
146
940
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.0
6.0
32
109
A07DA03
ATC
loperamide; oral
2.8
6.0
36
132
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.3
6.0
52
232
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
3.3
6.0
28
87
N02AJ13
ATC
tramadol and paracetamol; systemic
3.7
6.0
24
66
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021387) Prolactin [Units/volume] in Serum or Plasma
368
273
18.24
307.65
1.7
1.4
mu/l
233.3
247.2
0.37
345
256
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
700
631
22.26
307.65
3.2
1.7
pmol/l
208.9
221.7
1.42
691
597
(3017446) Testosterone [Moles/volume] in Serum or Plasma
1103
1951
27.97
307.65
6.0
2.0
nmol/l
13.0
14.5
7.20
1055
1784
(3009214) Lutropin [Units/volume] in Serum or Plasma
528
385
22.05
307.65
2.1
1.3
u/l
7.7
4.9
6.15
434
316
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
762
849
19.62
307.65
3.2
1.7
nmol/l
30.3
37.5
14.99
752
825
(3023323) Follitropin [Units/volume] in Serum or Plasma
220
138
18.90
264.58
2.0
1.3
iu/l
14.7
7.8
4.27
172
106
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1147
6700
6.10
136.63
4.7
3.8
ug/l
1.4
1.9
9.57
1081
6131
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
98
49
21.51
129.29
1.8
1.6
nmol/l
0.1
0.1
0.15
79
38
(3036481) Cortisol [Moles/volume] in Serum or Plasma
322
814
4.90
120.87
2.3
2.0
nmol/l
343.4
370.4
2.08
299
757
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
173
265
7.35
110.31
1.8
1.3
pmol/l
101.3
199.4
0.39
91
78
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
101
93
11.67
95.66
1.7
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
903
5327
3.15
84.25
3.9
3.3
%
23.6
21.0
4.00
340
2067
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1029
6748
3.30
75.73
3.9
2.9
pmol/l
14.5
14.8
3.87
967
6181
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
61
41
15.54
69.42
1.4
1.2
u/l
18.4
7.6
3.09
50
31
(3001122) Ferritin [Mass/volume] in Serum or Plasma
639
3449
2.64
64.80
3.2
2.6
ug/l
161.7
205.7
3.97
600
3240
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
697
3949
2.60
63.54
3.0
2.5
ug/l
0.6
0.7
0.49
385
2202
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
40
18
22.88
54.58
1.2
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1150
8795
3.24
50.73
4.8
3.5
mu/l
1.8
2.0
1.02
1094
8131
(3035637) Corticotropin [Mass/volume] in Plasma
70
92
7.97
50.48
1.4
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
57
71
8.34
42.92
6.5
5.0
u/l
4.4
35.4
—
19
10
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1015
7703
2.33
37.83
8.4
7.9
u/l
72.4
77.8
5.14
977
7366
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
541
3292
2.08
35.43
2.7
2.2
nmol/l
76.9
71.5
4.26
501
3039
(3001556) Androgen free Index in Serum or Plasma
25
10
25.46
35.40
1.4
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
40
52
7.90
29.02
1.0
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
161
627
2.78
28.98
2.0
1.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
716
5070
1.89
28.08
6.8
7.1
umol/l
12.7
12.8
0.10
688
4874
(3013826) Glucose [Moles/volume] in Serum or Plasma
807
5939
1.91
28.08
6.3
5.6
mmol/l
6.7
6.8
0.46
767
5642
(3037467) Urinalysis macro (dipstick) panel - Urine
843
6308
1.92
27.70
4.0
3.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1198
10254
2.66
26.77
15.4
11.7
ml/min/173m2
83.6
88.1
11.23
1070
8589
(40760892) CBC W Ordered Manual Differential panel - Blood
398
2365
1.97
26.22
4.7
4.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
64
146
4.55
26.17
1.1
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1175
10006
2.47
25.85
6.4
5.2
mmol/mol
40.1
39.8
0.37
1118
9497
(3022948) Iron [Moles/volume] in Serum or Plasma
277
1450
2.15
25.76
3.2
2.5
umol/l
15.9
14.3
1.99
254
1364
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
21
12
17.76
25.57
1.3
1.5
%
1.6
1.5
0.20
21
12
(3013707) Erythrocyte sedimentation rate by Westergren method
921
7186
1.91
25.54
4.3
3.7
mm/h
8.0
9.5
3.35
884
6759
(3002030) Lymphocytes/100 leukocytes in Blood
688
4923
1.82
25.00
7.2
6.8
%
28.3
28.0
0.27
660
4674
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
32
38
8.60
24.95
5.1
4.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
744
5455
1.82
24.90
4.0
3.4
e6/l
531.5
1139.6
—
10
69
(40761536) Microorganisms panel - Urine sediment
171
741
2.50
24.69
3.9
3.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
723
5265
1.82
24.65
7.2
6.9
e9/l
0.2
0.2
0.09
664
4684
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1266
11245
3.50
24.61
5.8
4.5
mmol/l
2.7
2.9
6.92
1211
10614
(3004789) Transferrin [Mass/volume] in Serum or Plasma
261
1357
2.15
24.60
3.2
2.5
g/l
2.4
2.3
2.15
235
1273
(3015377) Calcium [Moles/volume] in Serum or Plasma
436
2719
1.90
24.58
3.2
3.6
mmol/l
2.3
2.3
0.17
386
2445
(3019069) Monocytes/100 leukocytes in Blood
670
4772
1.81
24.57
7.4
7.1
%
9.0
9.0
0.07
644
4544
(3006504) Eosinophils/100 leukocytes in Blood
666
4741
1.81
24.41
7.2
6.8
%
3.0
3.0
0.14
640
4503
(3019550) Sodium [Moles/volume] in Serum or Plasma
1238
10872
2.95
24.37
19.6
14.8
mmol/l
139.6
139.7
0.90
1220
10631
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
529
3520
1.83
24.18
3.6
3.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
250
1287
2.16
24.13
3.3
2.5
%
26.6
25.0
1.00
213
1133
(3022096) Basophils/100 leukocytes in Blood
651
4616
1.80
24.06
7.3
6.9
%
0.7
0.7
0.41
626
4397
(3006315) Basophils [#/volume] in Blood
704
5111
1.80
24.01
6.8
6.6
e9/l
0.0
0.0
0.24
645
4473
(3021589) Normoblasts [#/volume] in Blood
638
4506
1.80
23.81
12.8
9.6
e9/l
0.1
0.0
0.51
574
3725
(3023103) Potassium [Moles/volume] in Serum or Plasma
1241
10936
2.95
23.79
19.8
14.9
mmol/l
4.0
4.0
2.55
1222
10692
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
623
4370
1.80
23.79
9.0
7.8
mmol/l
1.2
1.2
1.64
503
3785
(3018010) Neutrophils/100 leukocytes in Blood
675
4851
1.79
23.72
6.9
6.6
%
56.3
56.8
0.49
652
4616
(3019198) Lymphocytes [#/volume] in Blood
719
5265
1.79
23.70
6.8
6.7
e9/l
2.0
2.0
0.00
666
4680
(3024561) Albumin [Mass/volume] in Serum or Plasma
586
4040
1.80
23.69
5.6
5.8
g/l
37.0
36.3
2.38
562
3810
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
511
3387
1.82
23.49
2.0
1.8
pmol/l
96.1
94.3
0.43
292
1980
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
153
644
2.55
23.45
5.7
3.9
mmol/l
1.2
1.2
0.67
136
584
(3001604) Monocytes [#/volume] in Blood
701
5106
1.79
23.42
6.8
6.6
e9/l
0.6
0.6
0.18
643
4461
(40761511) CBC panel - Blood by Automated count
1270
11351
3.51
23.41
17.5
11.6
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
29
8
37.01
23.05
1.6
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
417
2611
1.87
22.91
3.0
2.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
576
3979
1.79
22.90
8.5
7.2
mmol/l
1.2
1.2
1.00
532
3668
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1253
11142
3.08
22.75
5.4
4.2
mmol/l
4.4
4.7
10.74
1199
10574
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1249
11089
3.00
22.72
5.4
4.1
mmol/l
1.2
1.3
31.43
1199
10491
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
532
3619
1.78
22.07
3.3
3.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
102
360
2.99
21.88
2.9
3.0
mg/l
1.4
1.4
0.14
94
344
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1216
10693
2.56
21.83
17.3
13.0
mg/l
22.1
25.3
3.04
1021
8373
(3009261) Glucose [Presence] in Urine by Test strip
637
4575
1.75
21.79
3.4
2.9
estimate
0.0
0.0
0.33
153
770
(3021601) Nitrite [Presence] in Urine by Test strip
632
4530
1.75
21.77
4.5
4.0
estimate
0.0
0.0
0.00
165
849
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1294
11787
4.34
21.35
12.5
9.7
u/l
35.6
34.1
1.54
1265
11492
(3035350) Ketones [Presence] in Urine by Test strip
631
4542
1.74
21.23
3.3
2.9
estimate
0.0
0.0
0.50
161
801
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1221
10790
2.57
21.08
4.9
3.8
mmol/l
1.6
1.5
6.13
1170
10182
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
557
3877
1.75
21.08
3.9
3.3
ng/l
30.1
45.2
1.55
390
2569
(3026493) Urate [Moles/volume] in Serum or Plasma
451
2954
1.80
21.05
3.0
2.6
umol/l
4268.5
4761.3
0.09
405
2677
(3002582) Erythrocytes [#/volume] in Urine
442
2887
1.79
20.77
3.7
3.1
e6/l
93.8
158.4
0.49
357
2228
(3002385) Erythrocyte distribution width [Ratio]
1067
8972
1.95
20.73
20.1
15.9
%
13.7
13.5
2.99
1051
8784
(3018418) pH of Serum or Plasma
395
2501
1.82
20.55
5.7
4.3
ph
7.4
7.4
0.40
120
478
(3000850) Epithelial cells [#/volume] in Urine
323
1923
1.90
20.42
2.9
2.5
e6/l
2.0
2.7
2.41
290
1692
(42870588) Differential panel, method unspecified - Blood
504
3437
1.75
20.31
6.9
6.7
—
—
—
0
0
(3026782) Osmolality of Urine
308
1810
1.91
20.24
2.9
2.6
mosm/kgh2o
568.3
593.4
1.05
272
1544
(3013650) Neutrophils [#/volume] in Blood by Automated count
758
5788
1.72
20.20
9.4
10.3
e9/l
4.3
4.2
0.29
693
5072
(3009508) Creatinine [Moles/volume] in Urine
488
3327
1.74
19.49
4.1
3.4
mmol/l
9.4
9.2
0.30
422
2861
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
67
197
3.53
19.37
1.3
1.2
u/l
13.9
55.0
1.92
62
168
(3044889) 12 lead EKG panel
922
7482
1.75
19.23
3.9
3.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
321
1954
1.85
18.73
2.4
2.1
mg/l
3.2
2.9
1.11
269
1697
(3021960) Folate [Moles/volume] in Serum or Plasma
303
1813
1.87
18.66
1.7
1.5
nmol/l
19.0
19.2
0.10
265
1603
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
527
3703
1.70
18.65
3.5
3.7
u/l
34.1
41.0
0.90
498
3508
(3030467) Casts [#/volume] in Urine by Automated count
402
2630
1.76
18.36
3.7
3.0
e6/l
0.4
0.4
0.33
316
1970
(3013512) EKG study
401
2627
1.75
18.20
4.1
3.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
397
2605
1.75
17.86
3.7
2.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
456
3124
1.70
17.46
2.6
2.8
u/l
56.1
59.1
0.81
427
2956
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1164
10252
2.07
17.46
5.0
4.1
mmol/l
6.1
6.0
0.34
1082
9552
(3012501) Base excess in Blood by calculation
71
233
3.16
17.26
4.2
4.3
mmol/l
2.2
2.2
0.03
51
144
(3027315) Oxygen [Partial pressure] in Blood
71
234
3.15
17.13
4.1
4.3
kpa
9.0
8.7
0.57
71
228
(3013290) Carbon dioxide [Partial pressure] in Blood
71
234
3.15
17.13
4.2
4.3
kpa
5.0
5.0
0.04
71
228
(3003458) Phosphate [Moles/volume] in Serum or Plasma
234
1325
1.93
16.92
8.3
7.2
mmol/l
1.0
1.0
0.02
225
1266
(1761868) Lipid panel - Serum or Plasma
647
4901
1.62
16.42
3.4
2.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
432
2958
1.68
16.36
3.6
3.3
mg/l
204.7
243.9
0.10
307
2045
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
312
1952
1.78
16.36
1.3
1.2
u/ml
2.6
1.9
0.22
97
559
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
992
8381
1.72
16.13
3.7
3.3
u/l
57.9
55.8
0.33
946
8004
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
430
2963
1.67
15.78
2.8
2.3
u/l
289.2
379.0
0.75
407
2815
(3018095) Leukocytes [#/volume] in Urine
461
3241
1.65
15.61
4.2
3.5
e6/l
88.7
61.7
0.32
371
2375
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
204
1132
1.95
15.58
5.2
4.8
u/l
237.9
237.3
0.01
194
1079
(3020682) Albumin/Creatinine [Ratio] in Urine
446
3116
1.65
15.44
4.7
4.1
mg/mmol
9.5
9.3
0.03
318
2151
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
285
1770
1.78
15.20
1.7
1.6
pmol/l
22449401.5
35267686.6
0.20
245
1534
(1616796) Gas panel - Central venous blood
66
226
3.02
14.94
4.0
3.8
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
136
660
2.18
14.92
7.6
10.1
mmol/l
24.8
24.9
0.06
136
653
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
97
407
2.49
14.87
3.2
3.6
pmol/l
4.8
4.7
0.42
88
374
(46235355) HIV 1 and 2 tests - Meaningful Use set
309
1977
1.73
14.81
2.2
1.9
—
—
—
0
0
(3015736) pH of Urine
487
3518
1.61
14.53
3.0
2.8
—
5.6
—
0
7
(3007461) Platelets [#/volume] in Blood
1312
12370
4.85
14.14
26.7
18.4
e9/l
231.9
239.3
4.84
1299
12100
(3032080) INR in Blood by Coagulation assay
540
4019
1.58
14.07
10.1
8.5
inr
1.2
1.2
1.25
220
1153
(3007164) IgA [Mass/volume] in Serum or Plasma
295
1888
1.72
14.04
1.7
1.5
g/l
2.4
2.7
2.49
213
1297
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
339
2253
1.68
14.02
2.1
1.9
mg/l
0.9
1.2
0.91
254
1656
(3035941) MCH [Entitic mass]
1312
12379
4.80
13.94
26.5
18.3
pg
30.4
30.5
1.59
1307
12241
(3024731) MCV [Entitic volume]
1312
12382
4.78
13.87
26.5
18.3
fl
90.3
90.4
0.42
1307
12244
(3026361) Erythrocytes [#/volume] in Blood
1312
12384
4.77
13.82
26.6
18.3
e12/l
4.9
4.8
20.76
1296
12093
(3000963) Hemoglobin [Mass/volume] in Blood
1312
12386
4.76
13.77
26.8
18.5
g/l
149.3
144.9
17.37
1306
12241
(3004588) Protein electrophoresis panel - Serum or Plasma
116
545
2.24
13.77
2.1
2.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1312
12390
4.74
13.68
26.7
18.4
e9/l
6.9
6.7
0.52
1296
12101
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
191
1084
1.89
13.54
2.3
2.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
196
1124
1.87
13.45
1.4
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
347
2357
1.64
13.06
3.6
3.3
estimate
0.0
0.0
0.06
157
779
(3023368) Bacteria identified in Blood by Culture
392
2744
1.61
13.05
5.0
4.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
389
2724
1.60
12.90
1.8
1.7
mmol/l
1.8
1.6
2.49
322
2334
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
203
1198
1.82
12.68
2.3
2.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
243
1521
1.73
12.39
3.0
2.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
58
209
2.86
12.03
2.7
2.6
%
18.4
17.2
0.82
32
111
(3012095) Magnesium [Moles/volume] in Serum or Plasma
258
1657
1.69
11.94
4.9
4.3
mmol/l
0.8
0.8
0.43
247
1583
(3019832) Treponema pallidum Ab [Presence] in Serum
130
678
2.02
11.76
2.0
1.9
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
104
499
2.18
11.72
4.6
4.5
ng/l
104.4
92.0
0.38
92
456
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
90
408
2.29
11.64
1.1
1.2
iu/ml
78.1
158.5
1.75
30
133
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
122
628
2.04
11.44
3.1
3.3
mmol/l
1.4
1.5
0.21
91
471
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
170
980
1.84
11.41
3.7
3.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
131
693
1.99
11.39
2.1
3.0
g/l
68.1
67.1
1.04
120
652
(3009343) pH of Capillary blood
124
649
2.00
11.11
3.2
3.3
ph
7.4
7.4
0.06
28
79
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
352
2485
1.57
11.00
3.2
3.1
ng/l
861.5
1253.8
1.59
275
2071
(3025159) Blasts/100 leukocytes in Blood
137
745
1.94
10.99
4.8
4.8
%
0.1
0.1
0.15
34
193
(40768804) Tissue Pathology biopsy report
449
3345
1.52
10.96
2.0
1.9
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
143
790
1.91
10.95
5.0
4.8
%
0.2
0.1
0.20
38
226
(3017181) Myelocytes/100 leukocytes in Blood
148
834
1.87
10.66
4.9
4.7
%
1.7
0.8
1.64
41
246
(3048689) Calprotectin [Mass/mass] in Stool
197
1213
1.73
10.55
2.7
2.8
ug/g
116.4
168.8
1.66
172
1044
(3019309) Folate [Moles/volume] in Red Blood Cells
216
1366
1.69
10.50
1.9
1.7
nmol/l
1244.5
1153.0
0.75
154
1084
(3002179) Metamyelocytes/100 leukocytes in Blood
138
767
1.89
10.36
4.6
4.4
%
0.8
0.6
0.75
35
191
(3037522) Nuclear Ab [Titer] in Serum
207
1304
1.70
10.19
1.4
1.3
titre
232.0
361.3
1.60
25
214
(3005719) IgG [Mass/volume] in Serum or Plasma
152
877
1.83
10.15
2.8
2.4
g/l
10.1
10.8
1.25
130
802
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
220
1413
1.67
10.06
1.3
1.2
iu/ml
21.4
27.4
0.41
58
417
(3009542) Hematocrit [Volume Fraction] of Blood
1153
10543
1.69
9.75
17.7
13.5
%
44.1
42.5
7.79
917
8402
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
71
315
2.32
9.68
2.9
3.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
62
260
2.45
9.57
3.0
3.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
105
553
1.98
9.25
1.2
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
51
199
2.62
9.15
3.9
3.9
%
54.0
55.5
0.40
51
199
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
39
132
3.01
9.09
5.5
3.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
98
513
1.98
8.79
1.5
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
49
193
2.60
8.64
3.1
3.7
e9/l
3.3
3.9
2.23
49
193
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
531
4256
1.41
8.28
4.4
4.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
166
1041
1.68
8.25
1.4
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
209
1392
1.59
8.18
2.8
3.6
mmol/l
2.4
2.4
1.24
188
1225
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
254
1770
1.54
8.15
1.5
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
45
176
2.61
8.06
3.0
2.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
218
1472
1.58
8.04
2.4
1.9
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
155
965
1.69
7.92
3.3
3.0
%
1.9
1.8
0.28
135
882
(3017143) Hepatitis C virus Ab [Presence] in Serum
220
1494
1.57
7.91
2.0
1.7
—
—
—
0
0
(4038314)
13
21
6.24
7.72
1.5
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
870
7635
1.40
7.68
3.1
2.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
216
1476
1.55
7.53
1.8
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
373
2847
1.43
7.51
2.5
2.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
48
202
2.43
7.41
2.4
2.3
g/l
145.7
135.0
1.35
37
145
(3023520) Reticulocytes [#/volume] in Blood
121
720
1.75
7.28
3.6
3.1
e9/l
77.4
70.7
0.77
88
549
(3002032) Base excess in Venous blood by calculation
149
941
1.66
7.20
5.1
4.3
mmol/l
1.7
1.9
0.22
126
754
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
14
27
5.23
6.98
2.1
2.4
ug/l
49.6
61.3
0.28
14
27
(40768797) Stomach Pathology biopsy report
187
1258
1.57
6.97
1.3
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
25
78
3.25
6.72
2.5
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
323
2447
1.42
6.67
7.8
7.9
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
147
948
1.62
6.54
5.0
4.3
kpa
6.0
5.9
0.74
139
920
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
27
90
3.04
6.52
2.4
2.0
%
15.0
13.8
0.22
12
37
(1002224) Polysomnography panel
120
735
1.70
6.52
1.2
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
16
37
4.36
6.50
1.4
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
189
1296
1.53
6.46
1.3
1.2
u/ml
1.4
8.8
4.97
81
563
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
56
270
2.12
6.33
1.4
2.5
g/l
10.5
10.6
0.09
50
235
(3007853) Bacteria identified in Skin by Aerobe culture
180
1229
1.54
6.27
2.3
1.8
—
—
—
0
0
(3002256) Pathology report gross observation
160
1065
1.57
6.24
1.5
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
73
390
1.92
6.23
2.2
2.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
42
181
2.36
6.20
2.8
2.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
346
2686
1.39
6.14
4.6
4.7
%
89.1
88.7
0.11
337
2644
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
294
2.05
6.13
1.4
2.5
g/l
7.4
7.1
0.39
48
227
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
294
2.05
6.13
1.4
2.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
294
2.05
6.13
1.4
2.5
g/l
3.8
3.9
0.31
43
215
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
18
48
3.79
6.10
1.1
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
211
1500
1.48
6.06
2.3
2.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
53
255
2.12
6.04
1.9
2.7
g/l
0.7
1.0
0.30
46
228
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
56
277
2.07
5.94
1.4
2.6
g/l
3.0
3.1
0.17
47
221
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
51
246
2.12
5.78
2.8
2.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
124
793
1.62
5.72
3.1
2.6
ml/min/173m2
62.4
72.1
1.46
51
265
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
87
509
1.76
5.59
1.8
2.1
u/l
43.3
39.5
0.85
76
458
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
78
442
1.81
5.57
1.1
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
49
237
2.11
5.53
1.2
1.4
e6/l
5.2
31.4
1.07
39
172
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
49
237
2.11
5.53
1.3
1.5
e6/l
167.4
1187.9
0.76
42
184
(21494890) Protein electrophoresis panel - 24 hour Urine
23
79
2.94
5.32
1.5
2.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
30
119
2.56
5.31
3.4
2.8
e9/l
1.1
1.2
0.10
24
63
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
214
1564
1.44
5.30
3.4
2.9
e6/l
0.5
0.5
0.25
119
850
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
49
243
2.06
5.20
2.9
2.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
104
653
1.64
5.17
1.5
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
83
492
1.73
5.11
3.1
3.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
37
166
2.26
5.04
2.6
1.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
50
253
2.01
5.03
3.6
3.5
mg/l
37.6
37.1
0.02
33
197
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
288
2237
1.37
4.98
2.5
2.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
72
413
1.79
4.97
2.0
1.8
mg/l
4.4
4.3
0.02
56
296
(3000991) Gas panel - Venous blood
136
922
1.53
4.90
11.0
11.7
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
86
522
1.69
4.88
6.1
4.3
mmol/l
23.8
24.2
0.52
80
472
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
172
1228
1.46
4.81
3.2
3.4
umol/l
9.5
9.2
0.05
158
1108
(3034860) Kappa light chains.free [Mass/volume] in Serum
49
253
1.97
4.68
3.7
3.5
mg/l
66.8
88.2
0.28
32
195
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
220
1652
1.40
4.66
3.4
2.7
e6/l
0.6
0.9
1.14
123
931
(3044290) Cell count panel - Cerebral spinal fluid
44
219
2.04
4.65
1.3
1.4
—
—
—
0
0
(4062490)
29
122
2.41
4.58
1.3
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
27
110
2.48
4.56
3.2
2.6
pg
33.4
33.9
0.29
27
110
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
46
235
1.99
4.54
1.5
2.6
g/l
38.2
37.9
0.09
41
203
(3024980) IgG subclass 4 [Mass/volume] in Serum
43
217
2.01
4.40
1.5
1.7
g/l
0.6
1.0
1.78
26
164
(3017732) Neutrophils [#/volume] in Blood
104
681
1.57
4.39
2.5
3.1
e9/l
4.5
4.0
1.20
91
561
(3022493) Free Hemoglobin [Mass/volume] in Plasma
16
50
3.23
4.34
4.1
6.8
mg/l
86.7
69.5
—
10
39
(3000570) Elastase.pancreatic [Mass/mass] in Stool
49
263
1.90
4.21
1.3
1.5
ug/g
345.7
264.2
2.21
33
156
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
13
36
3.64
4.21
2.6
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
32
147
2.21
4.17
2.4
1.9
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
21
79
2.68
4.17
1.3
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
251
1966
1.34
4.06
3.5
3.7
ng/l
1436.9
638.4
0.44
192
1518
(40760888) Immunoglobulin light chains.free panel - Serum
39
196
2.02
4.05
3.9
3.4
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
28
123
2.30
4.05
1.4
1.2
g/l
6.7
7.2
0.15
12
83
(3024139) IgG subclass 3 [Mass/volume] in Serum
28
123
2.30
4.05
1.4
1.2
g/l
0.4
0.4
0.06
12
81
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
25
105
2.41
3.99
1.2
1.2
pmol/l
303.5
308.0
0.02
19
82
(3028192) IgG subclass 2 [Mass/volume] in Serum
28
124
2.29
3.98
1.4
1.2
g/l
2.8
3.2
0.28
12
84
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
139
995
1.44
3.85
1.6
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
70
430
1.66
3.85
1.5
1.8
g/l
1.5
1.5
0.07
60
367
(3028707) Methadone [Presence] in Urine by Screen method
53
301
1.79
3.84
4.4
3.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
139
997
1.44
3.81
1.7
1.6
—
—
—
0
0
(3017704) Immunofixation for Urine
15
49
3.08
3.81
2.4
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
26
115
2.29
3.72
3.0
2.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
105
716
1.51
3.72
1.2
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
142
1031
1.42
3.65
2.3
1.8
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
13
40
3.27
3.63
1.1
1.0
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
133
956
1.43
3.62
2.5
2.5
g/l
0.2
0.2
0.39
127
886
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
49
278
1.79
3.58
9.6
7.3
iu/ml
135.8
1047.3
—
9
45
(3016750) Collection duration of Urine
18
68
2.67
3.57
2.3
2.4
min
506.5
499.4
0.08
11
49
(21494814) CD8 cells/100 lymphocytes in Specimen
15
52
2.91
3.47
2.5
2.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
16
58
2.78
3.42
2.9
1.9
u/l
189.1
204.7
0.41
16
58
(3000492) Spirometry study
178
1359
1.36
3.40
1.6
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
17
64
2.68
3.40
1.1
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
149
1106
1.39
3.39
5.1
4.1
%
27.1
28.7
1.08
116
803
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
54
324
1.69
3.28
1.8
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
41
228
1.82
3.23
1.2
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
195
1522
1.33
3.22
2.2
1.8
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
18
72
2.52
3.21
3.3
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
142
1056
1.39
3.20
2.5
1.8
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
14
49
2.88
3.19
1.3
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
271
2215
1.28
3.18
2.0
2.1
%
1.5
1.5
0.56
243
1998
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
25
118
2.14
3.11
1.5
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
91
629
1.48
3.06
4.3
3.7
g/l
137.5
135.0
0.40
86
616
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
40
225
1.80
3.05
1.7
1.7
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
16
5.02
3.05
1.1
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
26
127
2.07
2.98
2.3
2.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
160
1228
1.34
2.97
10.1
10.2
mmol/l
0.9
0.9
0.02
142
967
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
16
63
2.56
2.96
1.2
1.2
mmol/l
12.4
12.1
—
8
36
(3004809) Band form neutrophils/100 leukocytes in Blood
30
155
1.96
2.96
4.7
4.2
%
2.4
1.4
0.42
25
134
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
166
1282
1.34
2.95
1.4
1.4
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
28
142
1.99
2.91
1.0
1.1
—
41.6
—
0
10
(4094501)
58
367
1.61
2.91
1.2
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
21
95
2.23
2.90
2.3
2.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
21
95
2.23
2.90
2.3
2.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
21
95
2.23
2.90
2.3
2.3
—
—
—
0
0
(4024509)
14
52
2.71
2.89
1.4
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
102
730
1.43
2.88
3.1
2.6
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
45
268
1.70
2.85
1.1
1.1
u/ml
0.7
5.5
—
5
33
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
8
18
4.46
2.79
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
69
460
1.53
2.78
8.6
3.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
95
676
1.44
2.77
3.2
2.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
10
31
3.24
2.77
1.1
1.1
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
5
6
8.36
2.75
3.0
3.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
100
721
1.42
2.72
3.2
2.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
24
118
2.05
2.72
2.4
2.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
27
139
1.96
2.71
2.6
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
99
714
1.42
2.69
3.2
2.5
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
8
19
4.23
2.68
7.6
2.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
183
1.82
2.67
2.4
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
48
297
1.64
2.65
1.2
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
33
184
1.81
2.62
1.1
1.1
—
3.1
—
0
12
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
13
49
2.67
2.62
2.8
3.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
13
49
2.67
2.62
2.8
3.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
13
49
2.67
2.62
2.8
3.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
13
49
2.67
2.62
2.8
3.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
48
298
1.63
2.62
2.6
2.4
ug/min
303.2
138.6
0.43
30
182
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
39
229
1.72
2.61
1.1
1.1
iu/ml
375.8
65.1
—
5
61
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
55
354
1.58
2.60
3.1
3.0
g/l
3.6
3.6
0.04
55
339
(1001926) Buprenorphine [Presence] in Urine by Screen method
80
559
1.46
2.59
3.4
2.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
100
729
1.40
2.57
3.2
2.3
—
—
—
0
0
(4010399)
95
687
1.41
2.56
1.3
1.4
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
5
7
7.17
2.55
6.6
5.9
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
62
413
1.53
2.53
1.2
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
53
342
1.57
2.49
2.3
2.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
43
264
1.65
2.47
2.1
3.0
—
—
—
0
0
(3019225) pH of Specimen
105
780
1.38
2.43
5.1
4.4
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
19
90
2.13
2.39
2.2
2.4
ml
861.3
624.6
1.22
12
57
(3017817) Protein [Mass] in Urine collected for unspecified duration
20
97
2.08
2.38
3.3
2.9
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
25
132
1.91
2.37
1.2
1.1
mmol/l
8.0
7.0
0.32
20
104
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
28
154
1.84
2.35
1.1
1.1
u/ml
2.2
2.1
0.01
14
78
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
28
154
1.84
2.35
2.5
1.6
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
66
454
1.48
2.33
3.9
4.1
mmol/l
25.9
25.0
1.34
59
439
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
27
148
1.84
2.29
2.2
1.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
148
1170
1.30
2.27
15.4
20.5
inr
1.0
1.2
5.61
20
165
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
41
256
1.62
2.23
1.7
1.8
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
33
195
1.71
2.20
1.1
1.1
u/ml
1.7
1.5
0.05
15
79
(3000093) Morphology [Interpretation] in Blood Narrative
19
94
2.04
2.16
1.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
48
314
1.55
2.16
1.7
1.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
39
243
1.62
2.15
1.2
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
236
1986
1.23
2.14
3.3
3.1
kg/l
1.0
1.0
0.03
26
246
(3011648) Oxygen content in Venous blood
21
109
1.94
2.11
3.1
2.4
%
12.9
11.9
0.38
21
109
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
25
139
1.81
2.06
1.2
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
44
286
1.56
2.05
1.2
1.9
nmol/l
1.1
0.9
1.48
37
253
(3011397) Hemoglobin [Presence] in Urine by Test strip
238
2014
1.22
2.04
3.5
3.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
48
319
1.52
2.03
1.9
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
39
247
1.60
2.03
1.6
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
11
44
2.51
2.01
3.2
3.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
11
44
2.51
2.01
3.2
3.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
36
225
1.62
1.98
1.2
1.1
u/ml
4.2
2.0
0.32
17
92
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
26
149
1.76
1.95
1.1
1.1
—
2.0
—
0
11
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
51
2.37
1.95
3.4
2.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
51
2.37
1.95
3.3
2.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
55
380
1.47
1.95
1.3
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
51
347
1.49
1.94
3.5
3.9
g/l
0.3
0.3
0.04
30
201
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
22
120
1.85
1.93
2.8
3.0
e6/l
341.4
651.2
—
5
46
(3049717) Cytology report of Urine Cyto stain
56
389
1.46
1.93
3.0
2.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
11
45
2.46
1.93
3.2
3.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
58
2.25
1.91
3.1
1.9
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
33
204
1.63
1.90
1.1
1.1
u/ml
2.9
7.1
1.53
19
106
(3024869) Neuronal Ab [Presence] in Serum
7
22
3.19
1.88
1.1
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
7
22
3.19
1.88
3.4
2.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
21
114
1.86
1.87
5.1
4.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
29
174
1.68
1.87
1.3
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
15
72
2.10
1.86
1.1
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
41
269
1.54
1.86
1.8
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
16
79
2.04
1.85
1.8
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
39
254
1.55
1.83
4.7
3.5
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
12
4.18
1.82
1.6
2.9
ng/l
138.9
167.7
—
5
12
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
95
731
1.32
1.81
12.7
12.9
%
0.6
0.7
1.75
95
724
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
39
255
1.55
1.80
1.8
1.5
u/ml
106.4
118.3
—
10
47
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
9
35
2.58
1.80
1.3
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
19
102
1.88
1.76
2.5
4.5
%
54.8
57.3
0.14
12
78
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
95
734
1.32
1.76
12.7
12.7
%
1.4
1.5
0.08
95
729
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
14
67
2.10
1.76
3.2
2.9
u/ml
676.9
1136.3
0.63
14
67
(40761535) Cells panel - Urine sediment
97
752
1.31
1.76
3.2
3.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
12
54
2.23
1.74
1.1
1.1
iu/ml
162.1
269.1
0.81
12
54
(3010726) Horse dander IgE Ab [Units/volume] in Serum
31
194
1.61
1.72
1.1
1.1
u/ml
0.5
3.7
—
8
50
(3048879) Bone marrow aspiration report
8
30
2.68
1.72
4.1
2.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
22
125
1.77
1.72
1.6
1.4
—
—
—
0
0
(4035726)
94
728
1.31
1.72
1.4
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
18
96
1.89
1.71
1.1
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
318
2814
1.17
1.67
1.4
1.3
—
—
—
0
0
(4211845)
7
25
2.81
1.65
3.4
2.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
20
112
1.80
1.65
1.1
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
11
49
2.26
1.63
2.5
2.3
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
18
98
1.85
1.62
2.7
3.1
%
38.5
39.0
—
6
26
(3019420) Tryptase [Mass/volume] in Serum or Plasma
12
56
2.15
1.61
3.2
1.2
ug/l
12.0
7.9
0.52
12
50
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
12
56
2.15
1.61
1.0
1.1
%
—
71.4
—
0
5
(3000494) Fungus identified in Specimen by Culture
156
1300
1.23
1.58
1.8
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
124
1009
1.25
1.56
2.9
2.9
u/l
35.9
89.2
0.63
111
913
(3023430) Cat dander IgE Ab [Units/volume] in Serum
26
160
1.64
1.56
1.0
1.1
u/ml
4.5
3.0
0.23
12
71
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
76
580
1.33
1.56
1.7
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
10
44
2.28
1.53
1.3
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
92
724
1.29
1.52
2.9
2.8
ng/l
200.4
159.7
0.34
83
638
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
33
217
1.53
1.52
1.2
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
70
530
1.34
1.52
2.4
1.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
23
138
1.68
1.52
1.3
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
19
108
1.77
1.51
1.6
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
25
155
1.62
1.47
1.2
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
7
28
2.51
1.45
25.7
9.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
11
52
2.12
1.44
1.2
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
52
2.12
1.44
2.5
1.6
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
27
172
1.58
1.43
1.0
1.1
u/ml
0.7
3.0
2.21
11
73
(40757373) Influenza virus identified in Isolate
6
22
2.73
1.43
1.2
2.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
87
686
1.29
1.43
7.4
5.8
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
9
40
2.26
1.40
1.2
2.1
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
7
29
2.42
1.39
1.9
1.2
g/l
0.3
0.3
—
7
24
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
53
2.08
1.38
2.5
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
31
206
1.52
1.38
1.3
1.5
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
9
41
2.20
1.37
1.2
3.0
—
49643.7
—
0
9
(3020891) Body temperature
58
436
1.35
1.35
7.4
5.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
39
274
1.44
1.34
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
39
275
1.43
1.32
1.3
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
39
275
1.43
1.32
1.3
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
70
544
1.30
1.30
2.1
1.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
18
2.78
1.28
1.0
1.1
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
35
2.29
1.27
1.4
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
30
203
1.49
1.25
1.7
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
63
486
1.31
1.25
2.7
2.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
41
296
1.40
1.23
3.4
3.4
umol/l
41.7
38.9
0.21
35
264
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
19
2.64
1.21
1.0
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
7
145
0.48
1.20
24.1
14.3
nmol/l
827.9
821.1
—
7
140
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
20
125
1.61
1.18
1.1
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
23
149
1.55
1.17
1.3
1.5
promille
1.4
1.5
0.11
14
118
(3045683) HLA typing for celiac disease panel - Blood or Tissue
11
57
1.94
1.17
1.0
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
45
334
1.36
1.16
1.6
1.8
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
39
2.06
1.15
3.4
4.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
27
183
1.49
1.14
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
27
183
1.49
1.14
1.4
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
39
284
1.38
1.13
1.2
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
11
58
1.90
1.12
2.5
3.5
ph
7.4
7.4
—
5
19
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
40
2.01
1.12
1.1
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
47
354
1.34
1.11
3.2
3.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
40
294
1.37
1.10
1.3
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
7
31
2.26
1.10
1.0
1.4
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
7
31
2.26
1.10
1.4
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
16
96
1.67
1.10
2.5
2.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
39
286
1.37
1.09
1.3
1.2
u/ml
297.7
264.5
0.30
23
178
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
78
631
1.25
1.09
14.2
13.8
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
152
1.52
1.09
1.0
1.1
—
—
—
0
0
(44790049)
20
128
1.57
1.08
2.4
1.9
—
—
—
0
0
(44806118)
20
128
1.57
1.08
2.4
1.9
—
—
—
0
0
(44790047)
20
128
1.57
1.08
2.4
1.9
—
—
—
0
0
(44790048)
20
128
1.57
1.08
2.5
1.9
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
11
59
1.87
1.07
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
21
137
1.54
1.06
3.4
2.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
15
90
1.67
1.04
1.3
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
42
315
1.34
1.04
1.1
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
46
1.96
1.03
1.9
2.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
11
60
1.84
1.03
1.5
1.1
nmol/l
158.0
147.6
0.29
11
60
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
20
130
1.55
1.03
1.1
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
28
197
1.43
1.00
2.7
2.5
titre
640.0
1324.4
—
5
18
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
47
361
1.31
1.00
3.4
2.9
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
16
99
1.62
1.00
2.4
2.9
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
9
49
1.84
0.98
2.2
1.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
16
100
1.61
0.97
2.3
2.8
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
10
54
1.86
0.96
1.7
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
12
69
1.75
0.96
1.2
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
51
1.77
0.94
2.9
1.6
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
51
1.77
0.94
2.9
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
33
243
1.37
0.93
1.7
1.7
—
—
—
0
0
(4027681)
12
70
1.72
0.92
1.3
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
36
271
1.34
0.89
1.1
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
20
135
1.49
0.89
1.3
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
42
1.91
0.88
1.0
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
20
136
1.48
0.86
2.8
3.0
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
8
44
1.82
0.86
1.3
1.6
%
—
3.5
—
0
8
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
44
345
1.28
0.84
1.6
1.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
21
146
1.45
0.82
2.1
2.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
46
1.74
0.82
7.7
3.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
17
113
1.51
0.82
1.4
1.7
%
69.6
62.1
—
8
77
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
6
32
1.88
0.82
4.7
4.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
49
393
1.26
0.79
2.8
2.6
%
90.6
91.7
0.15
43
379
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
24
0.00
0.79
0.0
4.3
—
4108.7
—
0
24
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
34
1.77
0.76
1.0
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
56
459
1.23
0.76
1.3
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
13
83
1.57
0.75
1.9
3.3
—
—
—
0
0
(4268621)
20
141
1.42
0.74
2.7
2.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
7
38
1.85
0.73
1.0
1.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
25
2.00
0.72
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
23
168
1.38
0.71
1.6
1.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
21
151
1.40
0.71
1.2
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
20
143
1.40
0.70
1.2
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
20
143
1.40
0.70
2.4
2.3
—
—
—
0
0
(4146454)
7
119
0.59
0.68
3.9
2.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
44
357
1.24
0.67
4.0
3.1
u/ml
0.3
0.3
0.35
24
191
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
16
111
1.45
0.66
3.7
4.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
16
112
1.43
0.63
2.1
1.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
87
1.50
0.63
1.3
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
44
361
1.23
0.62
1.7
1.7
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
30
1.67
0.61
1.8
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
33
262
1.27
0.61
1.5
1.2
miu/ml
109.2
187.6
0.86
14
104
(3025468) Yersinia sp identified in Specimen by Organism specific culture
16
113
1.42
0.61
2.0
1.8
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
39
317
1.24
0.60
1.2
1.1
—
0.7
—
0
5
(40768806) Pleura Pathology biopsy report
12
80
1.50
0.60
1.5
1.6
—
—
—
0
0
(44813793)
8
52
1.54
0.59
1.0
1.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
16
114
1.41
0.59
2.0
1.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
16
114
1.41
0.59
2.0
1.8
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
47
391
1.21
0.59
6.9
4.6
mmol/l
1.3
1.4
0.48
47
384
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
22
166
1.33
0.58
1.4
1.8
iu/l
2.9
5.3
—
6
57
(4133840)
8
53
1.51
0.58
1.3
1.2
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
13
89
1.47
0.58
9.5
10.5
u/ml
31.9
196.4
—
7
42
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
35
1.72
0.57
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
54
1.48
0.57
1.8
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
54
1.48
0.57
1.8
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
54
1.48
0.57
1.8
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
36
292
1.24
0.57
1.3
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
16
115
1.40
0.56
2.1
1.8
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
16
115
1.40
0.56
2.1
1.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
11
73
1.51
0.56
1.2
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
13
90
1.45
0.55
1.2
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
62
1.45
0.53
1.2
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
64
1.41
0.51
1.0
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
24
188
1.28
0.51
3.4
3.4
mmol/l
1.3
1.7
1.88
24
182
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
13
92
1.42
0.50
1.3
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
41
1.47
0.50
2.3
2.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
19
145
1.31
0.49
1.1
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
14
102
1.38
0.47
2.1
1.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
68
1.47
0.47
2.1
3.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
7
50
1.40
0.45
2.9
2.8
ug/l
14.7
502.4
—
7
44
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
44
376
1.18
0.44
1.6
1.6
iu/ml
0.0
0.3
0.93
15
77
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
10
69
1.45
0.44
1.7
1.7
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
31
1.62
0.43
1.2
1.9
umol/l
10.9
15.7
—
5
31
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
56
1.43
0.42
1.8
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
56
1.43
0.42
1.8
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
56
1.43
0.42
1.8
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
22
176
1.25
0.42
1.3
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
15
0.00
0.41
0.0
2.3
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
16
0.00
0.41
0.0
2.3
—
—
—
0
0
(3036489) Thrombin time
49
427
1.15
0.40
3.0
2.4
s
21.4
21.8
0.29
40
377
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
31
260
1.20
0.39
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
31
260
1.20
0.39
1.2
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
13
97
1.34
0.39
1.2
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
25
205
1.22
0.39
1.6
1.2
u/ml
2.4
4.4
—
8
71
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
35
1.43
0.39
13.0
7.8
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
107
1.31
0.37
1.5
1.5
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
6
42
1.43
0.35
1.5
1.2
—
65.0
—
0
6
(3045424) Erythrocytes [Presence] in Urine
14
178
0.78
0.34
1.3
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
44
1.37
0.34
1.3
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
14
109
1.29
0.33
1.5
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
61
549
1.12
0.33
1.2
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
46
1.31
0.33
1.0
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
25
210
1.19
0.33
1.3
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
23
192
1.20
0.32
4.7
3.1
mg/l
21.6
26.2
0.26
16
122
(3003181) Sodium [Moles/volume] in Urine
17
137
1.24
0.32
1.4
1.3
mmol/l
77.0
65.6
0.40
12
111
(40768800) Prostate Pathology biopsy report
38
333
1.15
0.31
1.3
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
125
1171
1.07
0.30
9.4
6.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
10
75
1.34
0.30
1.0
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
75
1.34
0.30
1.6
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
56
1.25
0.29
1.9
1.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
37
326
1.14
0.29
9.4
7.4
mmol/l
1.4
1.3
0.28
31
280
(3021788) Differential panel - Synovial fluid
20
167
1.20
0.28
1.4
1.6
—
—
—
0
0
(4198724)
13
103
1.26
0.28
1.2
3.9
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
62
1.29
0.28
1.3
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
22
186
1.19
0.28
1.1
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
8
64
1.25
0.27
8.5
4.3
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
25
216
1.16
0.25
1.1
1.1
g/l
1.4
1.5
0.62
25
194
(3005570) Glucose [Moles/volume] in Urine
9
73
1.23
0.25
1.8
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
27
237
1.14
0.23
1.6
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
85
796
1.07
0.23
4.6
5.1
ug/l
18.1
24.6
0.18
77
669
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
39
1.28
0.23
13.0
7.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
101
952
1.07
0.23
2.9
2.2
ug/l
9.2
10.0
0.13
90
868
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
41
1.22
0.22
2.6
3.0
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
0.2
—
0
5
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
11
0.00
0.21
0.0
1.0
—
10.6
—
0
5
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
48
1.25
0.20
1.8
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
49
1.23
0.20
9.3
6.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
179
1855
0.96
0.19
1.3
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
58
1.21
0.18
1.0
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
61
1.15
0.17
1.3
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
69
1.16
0.16
2.1
5.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
71
1.13
0.16
1.9
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
26
235
1.11
0.15
1.3
1.7
e6/l
20722.4
18226.0
0.11
19
176
(3036782) Glucose [Moles/volume] in Pleural fluid
9
82
1.10
0.15
1.2
1.5
mmol/l
9.1
6.3
—
9
77
(3004616) Nuclear Ab [Presence] in Serum
11
93
1.18
0.14
1.3
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
48
452
1.06
0.13
1.5
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
35
375
0.93
0.12
1.1
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
21
191
1.10
0.11
4.5
3.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
106
1.13
0.09
1.3
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
47
1.06
0.09
1.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
48
1.04
0.09
7.8
4.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
6
54
1.11
0.09
1.2
3.1
—
—
—
0
0
(4306422)
23
214
1.08
0.08
1.3
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
60
0.83
0.08
1.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
10
88
1.14
0.08
1.5
1.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
67
1.05
0.08
1.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
75
0.80
0.07
1.3
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
75
0.80
0.07
1.3
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
12
108
1.11
0.07
1.6
1.4
g/l
0.9
1.0
0.63
12
108
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
81
0.86
0.07
1.0
1.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
11
99
1.11
0.06
1.5
1.6
g/l
31.0
33.3
0.40
11
87
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
148
1.08
0.06
1.3
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
15
162
0.93
0.06
1.3
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
100
1.10
0.05
1.3
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
100
1.10
0.05
1.3
1.0
—
—
—
0
0
(4034850)
35
339
1.03
0.03
15.2
9.6
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
19
199
0.95
0.03
1.8
1.2
u/ml
2.4
4.5
—
10
100
(40761995) Spermatozoa Progressive [#/volume] in Semen
11
108
1.02
0.00
2.2
3.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
11
108
1.02
0.00
4.4
6.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
125
0.96
0.00
1.3
1.3
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
1696.0
—
0
5
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
11.7
—
0
5
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.8
—
221.8
—
0
5
(3024932) HLA-DR beta [Type]
6
62
0.97
0.00
1.2
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3024471) HLA-A [Type]
6
62
0.97
0.00
1.0
1.0
—
—
—
0
0
(4212803)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
69
0.87
0.00
1.2
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
53
0.94
0.00
1.4
1.5
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
7.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
90
1.00
0.00
1.3
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
73
0.96
0.00
1.7
1.4
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.8
—
3.2
—
0
8
(3041672) Baker's yeast Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
57
0.88
0.00
1.4
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
52
0.96
0.00
1.2
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
52
0.96
0.00
1.2
1.7
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
8
0.00
0.00
0.0
5.1
—
513.3
—
0
8
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
9
0.00
0.00
0.0
3.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
51
0.98
0.00
1.4
1.1
miu/ml
1366.8
1414.2
—
5
51
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
46.8
—
0
7
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
58
0.86
0.00
1.0
1.3
—
3.2
—
0
6
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
6
0.00
0.00
0.0
2.0
—
1.1
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: E4_TESTIDYS – Testicular dysfunction
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).